Skip to main content
. 2020 May 25;68(3):17. doi: 10.1007/s00005-020-00581-7

Fig. 2.

Fig. 2

Differential effects of intravenous and subcutaneous administration of pure EPS-37 on the development of CIA. Mice immunized with CII in the presence of CFA (day 0, first immunization, sc) and with CII in the presence of LPS (day 21, second immunization, ip) were given saline (open circles) or EPS-37 (black circles) systemically, intravenously (a) or subcutaneously (b) three times a week starting on the day of second immunization (day 21) till the end of the experiment. Results are expressed as arthritis incidence—the percentage of mice with signs of arthritis and arthritis score expressed in points ± SEM. Data represent one out of three similar experiments